Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;59(9):1843-9.
doi: 10.1007/s00125-016-3892-9. Epub 2016 Apr 6.

MST1: a promising therapeutic target to restore functional beta cell mass in diabetes

Amin Ardestani  1 , Kathrin Maedler  2
Affiliations
Review

MST1: a promising therapeutic target to restore functional beta cell mass in diabetes

Amin Ardestani et al. Diabetologia. 2016 Sep.

Abstract

The loss of insulin-producing beta cells by apoptosis is a hallmark of all forms of diabetes mellitus. Strategies to prevent beta cell apoptosis and dysfunction are urgently needed to restore the insulin-producing cells and to prevent severe diabetes progression. We recently identified the serine/threonine kinase known as mammalian sterile 20-like kinase 1 (MST1) as a critical regulator of apoptotic beta cell death and dysfunction. MST1 activates several apoptotic signalling pathways, which further stimulate its own cleavage, leading to a vicious cycle of cell death. This led us to hypothesise that MST1 signalling is central to the initiation of beta cell death in diabetes. We found that MST1 is strongly activated in a diabetic beta cell and induces not only its death but also directly impairs insulin secretion through promoting proteasomal degradation of key beta cell transcription factor, pancreatic and duodenal homeobox 1 (PDX1), which is critical for insulin production.Pre-clinical studies in various animal models of diabetes have reported that MST1 deficiency remarkably restores normoglycaemia and beta cell function and prevents the development of diabetes. Importantly, MST1 deficiency can revert fully diabetic beta cells to a non-diabetic state. MST1 may serve as a target for the development of novel therapies for diabetes that trigger the cause of the disease, namely, the destruction of the beta cells. The major current focus of our investigation is to identify and test the efficacy of potent inhibitors of this death signalling pathway to protect beta cells against the effects of autoimmune attack in type 1 diabetes and to preserve beta cell mass and function in type 2 diabetes. This review summarises a presentation given at the 'Can we make a better beta cell?' symposium at the 2015 annual meeting of the EASD. It is accompanied by two other reviews on topics from this symposium (by Heiko Lickert and colleagues, DOI: 10.1007/s00125-016-3949-9 , and by Harry Heimberg and colleagues, DOI: 10.1007/s00125-016-3879-6 ) and a commentary by the Session Chair, Shanta Persaud (DOI: 10.1007/s00125-016-3870-2 ).

Keywords: Apoptosis; Beta cells; Diabetes; Hippo pathway; Insulin; Islets; MST1; Mammalian sterile 20-like kinase; PDX1; Review.

PubMed Disclaimer

Comment in

  • Can we make a better beta cell?
    Persaud SJ. Persaud SJ. Diabetologia. 2016 Sep;59(9):1832-3. doi: 10.1007/s00125-016-3870-2. Epub 2016 Apr 5. Diabetologia. 2016. PMID: 27048249 No abstract available.

Similar articles

  • Neratinib protects pancreatic beta cells in diabetes.
    Ardestani A, Li S, Annamalai K, Lupse B, Geravandi S, Dobrowolski A, Yu S, Zhu S, Baguley TD, Surakattula M, Oetjen J, Hauberg-Lotte L, Herranz R, Awal S, Altenhofen D, Nguyen-Tran V, Joseph S, Schultz PG, Chatterjee AK, Rogers N, Tremblay MS, Shen W, Maedler K. Ardestani A, et al. Nat Commun. 2019 Nov 1;10(1):5015. doi: 10.1038/s41467-019-12880-5. Nat Commun. 2019. PMID: 31676778 Free PMC article.
  • MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes.
    Ardestani A, Paroni F, Azizi Z, Kaur S, Khobragade V, Yuan T, Frogne T, Tao W, Oberholzer J, Pattou F, Conte JK, Maedler K. Ardestani A, et al. Nat Med. 2014 Apr;20(4):385-397. doi: 10.1038/nm.3482. Epub 2014 Mar 16. Nat Med. 2014. PMID: 24633305 Free PMC article.
  • Lipids and immunoinflammatory pathways of beta cell destruction.
    Imai Y, Dobrian AD, Morris MA, Taylor-Fishwick DA, Nadler JL. Imai Y, et al. Diabetologia. 2016 Apr;59(4):673-8. doi: 10.1007/s00125-016-3890-y. Epub 2016 Feb 11. Diabetologia. 2016. PMID: 26868492 Free PMC article. Review.
  • Targeting insulin-producing beta cells for regenerative therapy.
    Migliorini A, Roscioni SS, Lickert H. Migliorini A, et al. Diabetologia. 2016 Sep;59(9):1838-42. doi: 10.1007/s00125-016-3949-9. Epub 2016 Jul 13. Diabetologia. 2016. PMID: 27412250 Review.
  • Sources of beta cells inside the pancreas.
    De Groef S, Staels W, Van Gassen N, Lemper M, Yuchi Y, Sojoodi M, Bussche L, Heremans Y, Leuckx G, De Leu N, Van de Casteele M, Baeyens L, Heimberg H. De Groef S, et al. Diabetologia. 2016 Sep;59(9):1834-7. doi: 10.1007/s00125-016-3879-6. Epub 2016 Apr 6. Diabetologia. 2016. PMID: 27053238 Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Diabetes. 2001 Jan;50(1):77-82 - PubMed
    1. Endocrinology. 2004 Oct;145(10 ):4522-31 - PubMed
    1. J Clin Invest. 2010 Oct;120(10):3713-21 - PubMed
    1. Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1065-70 - PubMed
    1. Nature. 2001 Dec 13;414(6865):792-8 - PubMed

Publication types

MeSH terms

LinkOut - more resources